Edinburgh, Scotland-based start-up Trogenix has raised £70 million ($95 million) for a pipeline of therapies for hard-to-treat aggressive cancer, starting with glioblastoma. The University of Edinburgh spinout, set up in early 2024 by investment group 4BIO Capital, has the bold ambition of transforming cancer therapy from chronic disease management to potentially curative one-time treatments. Its…
Russia’s Enteromix Cancer Vaccine Shows 100% Success, Awaits Final Approval We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Health Bulletin 09/September/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Russia’s Enteromix Cancer Vaccine Shows 100% Success in Trial, Awaits Final Nod for Public Use We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link